Quick Answer ACCENDRA HEALTH INC/VA/ reported Cash and Equivalents of $281.99 million for fiscal year 2025. ACCENDRA HEALTH INC/VA/ Cash and Equivalents — Annual History Fiscal Year Cash and Equivalents YoY Change 2025 $281.99M +922.7% 2024 $27.57M -88.7% 2023 $243.04M +249.9% 2022 $69.47M +24.7% 2021 $55.71M -32.9% 2020 $83.06M +23.9% 2019 $67.03M +1.1% 2018 $66.31M … Read more
Quick Answer ACCENDRA HEALTH INC/VA/ reported Stockholders Equity of -$460.98 million for fiscal year 2025. ACCENDRA HEALTH INC/VA/ Stockholders Equity — Annual History Fiscal Year Stockholders Equity YoY Change 2025 -$460.98M -178.6% 2024 $586.36M -38.0% 2023 $945.30M -2.2% 2022 $966.74M +3.0% 2021 $938.50M +31.8% 2020 $712.05M +54.1% 2019 $462.15M -10.9% 2018 $518.42M -48.9% 2017 $1.02B … Read more
Quick Answer ACCENDRA HEALTH INC/VA/ reported Total Assets of $2.45 billion for fiscal year 2025. ACCENDRA HEALTH INC/VA/ Total Assets — Annual History Fiscal Year Total Assets YoY Change 2025 $2.45B -47.3% 2024 $4.66B -8.6% 2023 $5.09B -5.4% 2022 $5.39B +52.3% 2021 $3.54B +6.0% 2020 $3.34B -8.4% 2019 $3.64B -3.5% 2018 $3.77B +11.8% 2017 $3.38B … Read more
Quick Answer ACCENDRA HEALTH INC/VA/ reported Diluted EPS of $14.31 per share (loss) for fiscal year 2025. ACCENDRA HEALTH INC/VA/ Diluted EPS — Annual History Fiscal Year Diluted EPS YoY Change 2025 -$14.31 -202.5% 2024 -$4.73 -792.5% 2023 -$0.53 -282.8% 2022 $0.29 -90.1% 2021 $2.94 +525.5% 2020 $0.47 +145.6% 2019 -$1.03 -158.5% 2016 $1.76 +6.7% … Read more
Quick Answer ACCENDRA HEALTH INC/VA/ reported Revenue (ASC 606) of $2.76 billion for fiscal year 2025. ACCENDRA HEALTH INC/VA/ Revenue (ASC 606) — Annual History Fiscal Year Revenue (ASC 606) YoY Change 2025 $2.76B +3.1% 2024 $2.68B +5.0% 2023 $2.55B -74.4% 2022 $9.96B +1.7% 2021 $9.79B +15.4% 2020 $8.48B -7.9% 2019 $9.21B -2.2% 2018 $9.42B … Read more
Quick Answer ACCENDRA HEALTH INC/VA/ reported Net Income of -$1.10 billion for fiscal year 2025. ACCENDRA HEALTH INC/VA/ Net Income — Annual History Fiscal Year Net Income YoY Change 2025 -$1.10B -203.5% 2024 -$362.69M -778.2% 2023 -$41.30M -284.5% 2022 $22.39M -89.9% 2021 $221.59M +641.8% 2020 $29.87M +147.9% 2019 -$62.37M +85.7% 2018 -$437.01M -700.3% 2017 $72.79M … Read more
Quick Answer ACCENDRA HEALTH INC/VA/ reported Total Revenue of $2.76 billion for fiscal year 2025. ACCENDRA HEALTH INC/VA/ Total Revenue — Annual History Fiscal Year Total Revenue YoY Change 2025 $2.76B +3.1% 2024 $2.68B +5.0% 2023 $2.55B -74.4% 2022 $9.96B +1.7% 2021 $9.79B +15.4% 2020 $8.48B -7.9% 2019 $9.21B -2.2% 2018 $9.42B +1.1% 2017 $9.32B … Read more
Quick Answer ACCENDRA HEALTH INC/VA/ reported Total Revenue of $2.76 billion for fiscal year 2025. ACCENDRA HEALTH INC/VA/ — Key Financials by Year Metric 2025 2024 2023 2022 2021 2020 Total Revenue $2.76B+3.1% $2.68B+5.0% $2.55B-74.4% $9.96B+1.7% $9.79B+15.4% $8.48B-7.9% Revenue (ASC 606) $2.76B+3.1% $2.68B+5.0% $2.55B-74.4% $9.96B+1.7% $9.79B+15.4% $8.48B-7.9% Net Income -$1.10B-203.5% -$362.69M-778.2% -$41.30M-284.5% $22.39M-89.9% $221.59M+641.8% $29.87M+147.9% … Read more
Quick Answer Associated Capital Group, Inc. reported Shares Outstanding of 21.5 thousand shares for fiscal year 2023. Associated Capital Group, Inc. Shares Outstanding — Annual History Fiscal Year Shares Outstanding YoY Change 2023 21,538 -2.1% 2022 21,990 -99.9% 2021 22.06M -1.0% 2020 22.27M — Quarterly Shares Outstanding Quarter Ending Shares Outstanding YoY QoQ June 30, … Read more
Quick Answer Associated Capital Group, Inc. reported Operating Income of -$18.75 million for fiscal year 2024. Associated Capital Group, Inc. Operating Income — Annual History Fiscal Year Operating Income YoY Change 2024 -$18.75M -10.7% 2023 -$16.95M -50.5% 2022 -$11.26M +41.0% 2021 -$19.08M -53.0% 2020 -$12.47M +6.0% 2019 -$13.26M +1.6% 2018 -$13.48M +33.9% 2017 -$20.39M -66.7% … Read more